Active pharmaceutical ingredient: difference between revisions
Diff·revision 13 → 14·21:55, 9 May 2025
Difference between revision 13 and revision 14 of Active pharmaceutical ingredient. 2 lines changed; the page grew by 202 bytes.
| Revision 13 — 02:11, 23 Apr 2025 TrialsTabitha (talk) unpipe a link that did not need piping 3,553 bytes ±0 | Revision 14 — 21:55, 9 May 2025 CategoryBot (talk) bot: update parent category chain 3,755 bytes +202 | ||
|---|---|---|---|
| 32 | The first three are checkable because each names something external — a regulation, a monograph, a specification. The last two are supplier designations, and their meaning is exactly and only what the accompanying specification states.{{r|usp1503}} | 32 | The first three are checkable because each names something external — a regulation, a monograph, a specification. The last two are supplier designations, and their meaning is exactly and only what the accompanying specification states.{{r|usp1503}} |
| 33 | 33 | ||
| + | 34 | This is not a criticism of suppliers using the terms. It is an observation that a grade name is not a specification, and that the question worth asking of any grade claim is which document defines it. | |
| + | 35 | ||
| 34 | == References == | 36 | == References == |
| 35 | {{reflist}} | 37 | {{reflist}} |